Main menu


An innovative meeting focusing on immunotherapy-radiotherapy combinations!

The importance of immunology in tumor response to radiotherapy represents a major opportunity for our discipline. Novel therapies have emerged which target the immune cells. Combinations of such therapies to radiotherapy might translate into better local tumor control rates and also into better distant control given the possibility to use radiotherapy as an immunological enhancer of the anti-tumor immune response. Drugs targeting the immune checkpoints such as PD-1, PD-L1 and CTLA-4 blockers are among the first agents; moreover, several other agents are also in development. Thus, the selection of the optimal combination based on a sound rationale and proper patient selection will be key. 

Speakers from major European and North American institutions and from leading groups involved in the field will present their data in order to discuss clinical transfer opportunities. This meeting will be a unique opportunity to cover major fields including immunological biomarkers for patient selection, clinical trial design and proposals for innovative trial designs. Numerous prospects for brainstorming, learning and networking will also be available.

  Confirmed speakers

THURSDAY 20st SEP 2018

Alexander Eggermont (GRCC) ico fr
Andy Minn (University of Pennsylvania) ico usa
Aurélien Marabelle (GRCC) ico fr
Bill Mc Bride (UCLA) ico usa
Dominique Barbolosi (Aix-Marseille University) ico fr
Jérôme Galon (CRC) ico fr
Laurence Zitvogel (GRCC) ico fr
Lorenzo Galluzzi (Weil Cornell Medicine) ico usa
Stefan Michiels (GRCC) ico fr
Vincenzo Bronte (Verona) ico it

FRIDAY 21st SEP 2018

Alan Melcher (ICR) ico uk
David Raben (University of Colorado) ico usa
Dirk de Ruysscher (MAASTRO) ico nl
Enrico Giraudo (Torino) ico it
George Coukos (CHUV Lausanne) ico Sui
Ignacio Melero (CIMA) ico sp
Jim Welsh (MDA) ico usa
Kevin Harrington (ICR) ico uk
Ralf Weichselbaum (University of Chicago) ico usa
Sandra Demaria (Weil Cornell Medicine) ico usa
Silvia Formenti (Weil Cornell Medicine) ico usa
Tim Illidge (University of Manchester) ico uk

SATURDAY 22nd SEP 2018

Caroline Robert (GRCC) ico fr
Eric Deutsch (GRCC) ico fr
Guido Kroemer (GRCC) ico fr
Michele Mondini (GRCC) ico fr

Fees only for: Academia / non profit organizations, Industry and Gustave Roussy


carte credit
Tickets and registration

Until the
Until the
After the
Academia / non profit organizations 150 € 250 € 350 €
Academia / non profit organizations + Gala 200 € 320 € 440 €
Industry 450 € 550 € 650 €
Industry + Gala 500 € 620 € 740 €
Gala dinner only 50 € 70 € 90 €
Gustave Roussy 30 € 50 € 70 €
Gustave Roussy + Gala 55 € 85 € 115 €
 CLOSE Buy your ticket

Fees only for: Sponsors, Speaker

Tickets and registration

bt bill pink

opening of registration:

see you soon